181 related articles for article (PubMed ID: 10597047)
1. Functional characterization of TEL/AML1 fusion protein in the regulation of human CR1 gene promoter.
Song H; Kim JH; Rho JK; Park SY; Kim CG; Choe SY
Mol Cells; 1999 Oct; 9(5):560-3. PubMed ID: 10597047
[TBL] [Abstract][Full Text] [Related]
2. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
Lo Coco F; Pisegna S; Diverio D
Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
[TBL] [Abstract][Full Text] [Related]
3. Analysis of TEL proteins in human leukemias.
Poirel H; Lacronique V; Mauchauffé M; Le Coniat M; Raffoux E; Daniel MT; Erickson P; Drabkin H; MacLeod RA; Drexler HG; Ghysdael J; Berger R; Bernard OA
Oncogene; 1998 Jun; 16(22):2895-903. PubMed ID: 9671410
[TBL] [Abstract][Full Text] [Related]
4. Three distinct domains in TEL-AML1 are required for transcriptional repression of the IL-3 promoter.
Uchida H; Downing JR; Miyazaki Y; Frank R; Zhang J; Nimer SD
Oncogene; 1999 Jan; 18(4):1015-22. PubMed ID: 10023677
[TBL] [Abstract][Full Text] [Related]
5. AML-2 is a potential target for transcriptional regulation by the t(8;21) and t(12;21) fusion proteins in acute leukemia.
Meyers S; Lenny N; Sun W; Hiebert SW
Oncogene; 1996 Jul; 13(2):303-12. PubMed ID: 8710369
[TBL] [Abstract][Full Text] [Related]
6. The t(8;21) fusion protein, AML1/ETO, transforms NIH3T3 cells and activates AP-1.
Frank RC; Sun X; Berguido FJ; Jakubowiak A; Nimer SD
Oncogene; 1999 Mar; 18(9):1701-10. PubMed ID: 10208431
[TBL] [Abstract][Full Text] [Related]
7. TEL-AML1 translocations with TEL and CDKN2 inactivation in acute lymphoblastic leukemia cell lines.
Kim DH; Moldwin RL; Vignon C; Bohlander SK; Suto Y; Giordano L; Gupta R; Fears S; Nucifora G; Rowley JD
Blood; 1996 Aug; 88(3):785-94. PubMed ID: 8704231
[TBL] [Abstract][Full Text] [Related]
8. The AML1/ETO fusion protein blocks transactivation of the GM-CSF promoter by AML1B.
Frank R; Zhang J; Uchida H; Meyers S; Hiebert SW; Nimer SD
Oncogene; 1995 Dec; 11(12):2667-74. PubMed ID: 8545124
[TBL] [Abstract][Full Text] [Related]
9. Structure and possible mechanisms of TEL-AML1 gene fusions in childhood acute lymphoblastic leukemia.
Wiemels JL; Greaves M
Cancer Res; 1999 Aug; 59(16):4075-82. PubMed ID: 10463610
[TBL] [Abstract][Full Text] [Related]
10. TEL/AML1 fusion gene resulting from a cryptic t(12;21) is uncommon in adult patients with B-cell lineage ALL and CML lymphoblastic transformation.
Hoshino K; Asou N; Suzushima H; Osato M; Yamasaki H; Okubo T; Nishimura S; Kiyokawa T; Kawano F; Takatsuki K
Int J Hematol; 1997 Aug; 66(2):213-8. PubMed ID: 9277052
[TBL] [Abstract][Full Text] [Related]
11. Occurrence of TEL-AML1 fusion resulting from (12;21) translocation in human early B-lineage leukemia cell lines.
Uphoff CC; MacLeod RA; Denkmann SA; Golub TR; Borkhardt A; Janssen JW; Drexler HG
Leukemia; 1997 Mar; 11(3):441-7. PubMed ID: 9067587
[TBL] [Abstract][Full Text] [Related]
12. Lack of TEL-AML1 fusion transcript resulting from a cryptic t(12;21) in adult B lineage acute lymphoblastic leukemia in Taiwan.
Shih LY; Chou TB; Liang DC; Tzeng YS; Rubnitz JE; Downing JR; Pui CH
Leukemia; 1996 Sep; 10(9):1456-8. PubMed ID: 8751462
[TBL] [Abstract][Full Text] [Related]
13. AML1 gene amplification: a novel finding in childhood acute lymphoblastic leukemia.
Niini T; Kanerva J; Vettenranta K; Saarinen-Pihkala UM; Knuutila S
Haematologica; 2000 Apr; 85(4):362-6. PubMed ID: 10756360
[TBL] [Abstract][Full Text] [Related]
14. TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis.
Shurtleff SA; Buijs A; Behm FG; Rubnitz JE; Raimondi SC; Hancock ML; Chan GC; Pui CH; Grosveld G; Downing JR
Leukemia; 1995 Dec; 9(12):1985-9. PubMed ID: 8609706
[TBL] [Abstract][Full Text] [Related]
15. The AML1/Evi-1 fusion protein in the t(3;21) translocation exhibits transforming activity on Rat1 fibroblasts with dependence on the Evi-1 sequence.
Kurokawa M; Ogawa S; Tanaka T; Mitani K; Yazaki Y; Witte ON; Hirai H
Oncogene; 1995 Sep; 11(5):833-40. PubMed ID: 7675444
[TBL] [Abstract][Full Text] [Related]
16. TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia.
McLean TW; Ringold S; Neuberg D; Stegmaier K; Tantravahi R; Ritz J; Koeffler HP; Takeuchi S; Janssen JW; Seriu T; Bartram CR; Sallan SE; Gilliland DG; Golub TR
Blood; 1996 Dec; 88(11):4252-8. PubMed ID: 8943861
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of the AML1 proto-oncoprotein in NIH3T3 cells leads to neoplastic transformation depending on the DNA-binding and transactivational potencies.
Kurokawa M; Tanaka T; Tanaka K; Ogawa S; Mitani K; Yazaki Y; Hirai H
Oncogene; 1996 Feb; 12(4):883-92. PubMed ID: 8632911
[TBL] [Abstract][Full Text] [Related]
18. [Detection of BCR/ABL, MLL/AF4 and TEL/AML1 hybrid genes and monitoring of minimal residual disease in pediatric patients with acute lymphoblastic leukemia].
Trka J; Zuna J; Haskovec C; Brabencová A; Kalinová M; Muzíková K; Paukertová R; Hrusák O; Zemanová Z; Michalová K; Starý J
Cas Lek Cesk; 1999 Jan; 138(1):12-7. PubMed ID: 10953429
[TBL] [Abstract][Full Text] [Related]
19. Block of granulocytic differentiation of 32Dcl3 cells by AML1/ETO(MTG8) but not by highly expressed Bcl-2.
Kohzaki H; Ito K; Huang G; Wee HJ; Murakami Y; Ito Y
Oncogene; 1999 Jul; 18(28):4055-62. PubMed ID: 10435586
[TBL] [Abstract][Full Text] [Related]
20. Correlation between cellular localization of TEL/AML1 fusion protein and repression of AML1-mediated transactivation of CR1 gene.
Rho JK; Kim JH; Yu J; Choe SY
Biochem Biophys Res Commun; 2002 Sep; 297(1):91-5. PubMed ID: 12220513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
